5,7-DICHLORO-1H-PYRAZOLO[3,4-C]PYRIDINE, 95%, 500mg

(1H-Indol-4-yl)methanamine, 97.0%, 2.5g

5-amino-2,4-dichlorobenzoic acid, 95.0%, 5g

2,6-Dimethyl-4-ethoxybenzaldehyde, 97.0%, 1g

tert-Butyl (2R,3S)-(-)-6-oxo-2,3-diphenyl-4-morpholinecarboxylate, 98.0%, 25g

Cis-dimethyl cyclohexane-1,2-dicarboxylate, 95%, 100g

1-(3-chlorophenyl)-4-cyclopropyl-1,6-dihydro-7H-pyrazolo[3,4-d]pyridazin-7-one, 95.0%, 500mg

2-(Dichloromethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 1g

tert-butyl 4-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-1-carboxylate, 95.0%, 2g

2-Bromo-5-methylaniline>97.0%(GC)(T)5g

oxalic acid; tert-butyl 4-hydrazinylpiperidine-1-carboxylate, 97, 5g

1-((4-Bromophenyl)sulfonyl)piperidine, 95.0%, 250mg

Volumetric flasks DURAN® Class A, with individual certificate, 50 ml, 12/21, 2 Piece(s)